abstract |
The invention relates to compounds of formula I and salts thereof n n n n n n n n n n wherein the substituents are as defined in the specification, processes for the preparation thereof; to pharmaceuticals containing such compounds, in particular for the use in one or more Protein tyrosine kinase mediated diseases. |